Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gastpar

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Journal of Psychopharmacology (Oxford, England)|September 8, 2005
Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapineM Gastpar, M Masiak, M A Latif, et al.
European Journal of Medical Research|March 5, 2009
Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trialH Wieneke, H Conrads, J Wolstein, et al.
Der Nervenarzt|March 1, 1997
[Early and differential diagnosis of 1,000 patients examined in a memory clinic]G Heuft, H G Nehen, J Haseke, et al.
Pharmacopsychiatry|January 21, 2009
A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addictionJ Wolstein, M Gastpar, T Finkbeiner, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometryC B Eap, G Bouchoux, N Scherbaum, et al.
Neuropsychobiology|January 1, 1984
Efficacy and tolerability of dibenzepin administered by intravenous drip infusion to severely depressed patientsM Gastpar, F Cornu, J Faessler, et al.
International Journal of Psychiatry in Clinical Practice|March 21, 2017
Silexan does not cause withdrawal symptoms even when abruptly discontinuedM Gastpar, W E Müller, H P Volz, et al.
Cephalalgia : an International Journal of Headache|August 22, 2006
Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structuresI Ayzenberg, M Obermann, P Nyhuis, et al.
Pharmacopsychiatry|May 1, 1988
WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative StudyP Bech, L Eplov, M Gastpar, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 18, 2007
Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trialsS Kasper, M Gastpar, W E Müller, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Journal of Psychopharmacology (Oxford, England)|September 8, 2005
Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapineM Gastpar, M Masiak, M A Latif, et al.
European Journal of Medical Research|March 5, 2009
Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trialH Wieneke, H Conrads, J Wolstein, et al.
Der Nervenarzt|March 1, 1997
[Early and differential diagnosis of 1,000 patients examined in a memory clinic]G Heuft, H G Nehen, J Haseke, et al.
Pharmacopsychiatry|January 21, 2009
A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addictionJ Wolstein, M Gastpar, T Finkbeiner, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Determination of human plasma levels of levo-alpha-acetylmethadol and its metabolites by gas chromatography-mass spectrometryC B Eap, G Bouchoux, N Scherbaum, et al.
Neuropsychobiology|January 1, 1984
Efficacy and tolerability of dibenzepin administered by intravenous drip infusion to severely depressed patientsM Gastpar, F Cornu, J Faessler, et al.
International Journal of Psychiatry in Clinical Practice|March 21, 2017
Silexan does not cause withdrawal symptoms even when abruptly discontinuedM Gastpar, W E Müller, H P Volz, et al.
Cephalalgia : an International Journal of Headache|August 22, 2006
Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structuresI Ayzenberg, M Obermann, P Nyhuis, et al.
Pharmacopsychiatry|May 1, 1988
WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative StudyP Bech, L Eplov, M Gastpar, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 18, 2007
Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trialsS Kasper, M Gastpar, W E Müller, et al.
Pageof 14